Globus Medical (GMED) net assets (shareholders' equity)

Net assets · fiscal 2025
$4.57B

Globus Medical (GMED) had net assets of $4.57B at the end of fiscal 2025 (December 31, 2025). That is 9.5% higher than the $4.18B of fiscal 2024. Figures as of 19 Nov 2026, 11:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$4.57B
Change on fiscal 2024
+9.5%
Growth, 5 years
+24.9% a year
Growth, 10 years
+20.4% a year
Highest on record
$4.57Bfiscal 2025
Lowest on record
$228.20Mfiscal 2010
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Globus Medical net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 24.9% a year; over ten years the rate was 20.4% a year. Across the 16 fiscal years on record (2010–2025), the highest was $4.57B in fiscal 2025 and the lowest $228.20M in fiscal 2010.

History · 16 fiscal years

Net assets by fiscal year

Globus Medical net assets (shareholders' equity), year by year

Globus Medical (GMED) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$4.57B 9.5% up
2024$4.18B 4.5% up
2023$4.00B 116.5% up
2022$1.85B 6.0% up
2021$1.74B 15.6% up
2020$1.51B 7.4% up
2019$1.40B 18.3% up
2018$1.19B 22.5% up
2017$967.78M 16.3% up
2016$832.08M 16.3% up
2015$715.32M 22.2% up
2014$585.45M 23.9% up
2013$472.36M 22.2% up
2012$386.50M 36.8% up
2011$282.48M 23.8% up
2010$228.20M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Globus Medical and comparable companies
CompanyNet assetsFiscal year
Spyre Therapeutics SYRE$715.24M2025
Qiagen QGEN$3.78B2025
Insulet PODD$1.52B2025
Bruker BRKR$2.51B2025
Globus Medical GMED$4.57B2025
Madrigal Pharmaceuticals MDGL$602.69M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GMED

Globus Medical, figure by figure

Globus Medical (GMED) overview: price, valuation and scorecardAll health care companies by market value

Globus Medical net assets (shareholders' equity): questions and answers

What are Globus Medical's net assets?

Globus Medical (GMED) had net assets of $4.57B at the end of fiscal 2025 (December 31, 2025). That is 9.5% higher than the $4.18B of fiscal 2024.

What is the growth rate of Globus Medical's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 24.9% a year; over ten years the rate was 20.4% a year.

What are the highest and lowest net assets figures on record for Globus Medical?

Across the 16 fiscal years on record (2010–2025), the highest was $4.57B in fiscal 2025 and the lowest $228.20M in fiscal 2010.

How is Globus Medical's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Globus Medical it is on record here for 16 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Globus Medical (GMED) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/GMED/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.